In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Demo Video
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit My Profile
  • View/Edit My Portfolio

Email Updates

AlphaRx > Message
Generic_profile

Re: Listing of Robust Products

Posted by: mavenwood on September 27, 2007 10:11AM

In response to: Re: Listing of Robust Products by BundPataka

I have been an ALRX shareholder since 2004, possibly earlier. The next month will be crucial and I am expectant of some real results. Indaflex may well be approved to move to phase 3 or, in fact, it may already have. If it does (or has), the money is available immediately through Proprius and the test may be very simple and short term. Thus, the product could be on the market in a few months. Needless to say, at this point I'm not selling any of 1.5M shares.
Post a Reply

Please login to reply to this message.

Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote